Innoviva (INVA) Dividends Paid - Common (2014 - 2022)
Innoviva (INVA) posted Dividends Paid - Common of $69.8 million for Q3 2022, up 631.23% on a QoQ basis from $9.5 million in Q2 2022, and up 50.59% year-over-year from $46.4 million in Q3 2021.
Innoviva (INVA) Dividends Paid - Common (2014 - 2022) Analysis & Trends
Innoviva's Dividends Paid - Common history runs 9 years deep, the most recent figure standing at $69.8 million for Q3 2022.
- Quarterly Dividends Paid - Common rose 50.59% year-over-year to $69.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2023 was $69.8 million (down 47.2% YoY) and the FY2022 annual result came in at $69.8 million, up 17.41% from the prior year.
- Dividends Paid - Common was $69.8 million for Q3 2022 at Innoviva, up from $9.5 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $69.8 million in Q3 2022 and bottomed at -$10.5 million in Q4 2019.
- A 5-year average of $13.1 million and a median of $8.0 million in 2022 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2019 — Dividends Paid - Common plunged 443.72% — and 2020, when it jumped 110372.73%.
- Innoviva's Dividends Paid - Common stood at $3.1 million in 2018, then plunged by 443.72% to -$10.5 million in 2019, then jumped by 123.83% to $2.5 million in 2020, then soared by 1745.46% to $46.4 million in 2021, then surged by 50.59% to $69.8 million in 2022.
- Business Quant data shows INVA's Dividends Paid - Common at $69.8 million in Q3 2022, $9.5 million in Q2 2022, and $6.5 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 69.81 Mn |
| Sep 30, 2022 | 69.81 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Dec 31, 2019 | -10.54 Mn |
| Dec 31, 2019 | -10.54 Mn |